NASDAQ:TECH
BIO-TECHNE Corp
BIO-TECHNE Corp's revenue fell 0.4% in fiscal 2026 to $1.2B while operating margin rose to 20.7%. Free cash flow was $263.2M, 21.7% of revenue, and the diluted share count fell 1.7%.Summary generated from BIO-TECHNE Corp's SEC filings. Latest annual report filed Aug 24, 2026.
Key statistics
Fiscal 2026 from SEC filings. MethodologyRevenue (FY26)$1.2B
Revenue growth−0.4%
Revenue, 5-yr CAGR+5.5%
Gross margin65.8%
Operating margin20.7%
Net margin15.0%
ROIC9.2%
Return on equity9.0%
Debt / equity0.09
Free cash flow$263.2M
FCF margin21.7%
Share count change−1.7%
Financials
| Item | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Revenue | 1,106 | 1,137 | 1,159 | 1,220 | 1,215 |
| Operating income | 297 | 299 | 207 | 102 | 252 |
| Net income | 272 | 285 | 168 | 73 | 182 |
| Free cash flow | 280 | 216 | 236 | 257 | 263 |
Recent filings
- 4Insider transaction report
Sep 30, 2026 - 4Insider transaction report
Sep 24, 2026 - 8-KResults of a shareholder vote
Sep 23, 2026 - 8-KOther events
Sep 14, 2026 - 10-KAnnual report for the fiscal year ended Jun 30, 2026
Aug 24, 2026 - 8-KResults of operations and financial condition
Aug 12, 2026 - 8-KEntry into a material agreement
Jun 26, 2026 - 8-KRegulation FD disclosure
Jun 25, 2026